CONMED Corp — Director's Dealing 2018

Jun 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-06-01

Reporting Person: Pelletier Johonna Marie (Treasurer and VP, Tax)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-01	Common Stock	M	280	—	Acquired	3262	Direct
2018-06-01	Common Stock	F	138	$69.03	Disposed	3124	Direct
2018-06-01	Common Stock	M	195	—	Acquired	3319	Direct
2018-06-01	Common Stock	F	96	$69.03	Disposed	3223	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-01	Rsus (restricted Stock Units)	$0	M	280	Disposed	2023-06-01	Common Stock (280)	Direct
2018-06-01	Rsus (restricted Stock Units)	$0	M	195	Disposed	2024-06-01	Common Stock (195)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.